CD300 molecule regulation of human dendritic cell functions

Immunology Letters

Volumn 149, Issue 1-2, 2013, Pages 93-100

  Gasiorowski, Robin E ^a   Ju, Xinsheng ^a   Hart, Derek N J ^a   Clark, Georgina ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CD300; Human dendritic cells

Indexed keywords

CD300 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SURFACE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; MONOCYTE; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AUTOCRINE COMMUNICATION; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MYELOID CELLS; PROTEIN MULTIMERIZATION; RECEPTORS, IMMUNOLOGIC;

EID: 84873161809     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.10.005     Document Type: Review

References (72)

1. Chow A., Brown B.D., Merad M. Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol 2011, 11:788-798.
2. Palucka K., Banchereau J., Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity 2010, 33:464-478.
3. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
4. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
5. + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010, 207:1247-1260.
6. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010, 234:142-162.
7. Matsui T., Connolly J.E., Michnevitz M., Chaussabel D., Yu C.I., Glaser C., et al. CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J Immunol 2009, 182:6815-6823.
8. Randolph G.J., Ochando J., Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008, 26:293-316.
9. + dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 2012, 209:935-945.
10. Clark G.J., Ju X., Tate C., Hart D.N. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 2009, 30:209-217.
11. Green B.J., Clark G.J., Hart D.N. The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor. Int Immunol 1998, 10:891-899.
12. Jackson D.G., Hart D.N., Starling G., Bell J.I. Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor. Eur J Immunol 1992, 22:1157-1163.
13. Takatsu H., Hase K., Ohmae M., Ohshima S., Hashimoto K., Taniura N., et al. CD300 antigen like family member G: a novel Ig receptor like protein exclusively expressed on capillary endothelium. Biochem Biophys Res Commun 2006, 348:183-191.
14. Martinez-Barriocanal A., Comas-Casellas E., Schwartz S., Martin M., Sayos J. CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J Biol Chem 2010, 285:41781-41794.
15. Cannon J.P., Haire R.N., Mueller M.G., Litman R.T., Eason D.D., Tinnemore D., et al. Ancient divergence of a complex family of immune-type receptor genes. Immunogenetics 2006, 58:362-373.
16. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164:4991-4995.
17. Klesney-Tait J., Turnbull I.R., Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006, 7:1266-1273.
18. Viertlboeck B.C., Schmitt R., Gobel T.W. The chicken immunoregulatory receptor families SIRP, TREM, and CMRF35/CD300L. Immunogenetics 2006, 58:180-190.
19. Stet R.J., Hermsen T., Westphal A.H., Jukes J., Engelsma M., Lidy Verburg-van Kemenade B.M., et al. Novel immunoglobulin-like transcripts in teleost fish encode polymorphic receptors with cytoplasmic ITAM or ITIM and a new structural Ig domain similar to the natural cytotoxicity receptor NKp44. Immunogenetics 2005, 57:77-89.
20. Tadiso T.M., Sharma A., Hordvik I. Analysis of polymeric immunoglobulin receptor- and CD300-like molecules from Atlantic salmon. Mol Immunol 2011, 49:462-473.
21. Chung D.H., Humphrey M.B., Nakamura M.C., Ginzinger D.G., Seaman W.E., Daws M.R. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 2003, 171:6541-6548.
22. Bustamante C.D., Fledel-Alon A., Williamson S., Nielsen R., Hubisz M.T., Glanowski S., et al. Natural selection on protein-coding genes in the human genome. Nature 2005, 437:1153-1157.
23. Nielsen R., Bustamante C., Clark A.G., Glanowski S., Sackton T.B., Hubisz M.J., et al. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol 2005, 3:e170.
24. Lankry D., Simic H., Klieger Y., Levi-Schaffer F., Jonjic S., Mandelboim O. Expression and function of CD300 in NK cells. J Immunol 2010, 185:2877-2886.
25. Alvarez-Errico D., Aguilar H., Kitzig F., Brckalo T., Sayos J., Lopez-Botet M. IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur J Immunol 2004, 34:3690-3701.
26. Can I., Tahara-Hanaoka S., Shibuya A. Expression of a splicing isoform of MAIR-V (CD300LF), an inhibitory immunoglobulin-like receptor on myeloid cells. Hybridoma (Larchmt) 2008, 27:59-61.
27. Comas-Casellas E., Martínez-Barriocanal A., Miró F., Ejarque-Ortiz A., Schwartz S., Martín M., et al. Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. J Biol Chem 2012, 287:9682-9693.
28. Alvarez Y., Tang X., Coligan J.E., Borrego F. The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling. Mol Immunol 2008, 45:253-258.
29. Aguilar H., Alvarez-Errico D., Garcia-Montero A.C., Orfao A., Sayos J., Lopez-Botet M. Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol 2004, 173:6703-6711.
30. Clark G.J., Ju X., Azlan M., Tate C., Ding Y., Hart D.N. The CD300 molecules regulate monocyte and dendritic cell functions. Immunobiology 2009, 214:730-736.
31. Clark G.J., Jamriska L., Rao M., Hart D.N. Monocytes immunoselected via the novel monocyte specific molecule, CD300e, differentiate into active migratory dendritic cells. J Immunother 2007, 30:303-311.
32. Wu Y., Chen Q., Pai T., Ross A.C. All-trans-retinoic acid and Erk1/2 signaling synergistically regulate the expression of CD300B in human monocytic cells. Cell Immunol 2011, 268:68-78.
33. Daish A., Starling G.C., McKenzie J.L., Nimmo J.C., Jackson D.G., Hart D.N. Expression of the CMRF-35 antigen, a new member of the immunoglobulin gene superfamily, is differentially regulated on leucocytes. Immunology 1993, 79:55-63.
34. Ju X., Zenke M., Hart D.N., Clark G.J. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 2008, 112:1184-1194.
35. Bachelet I., Munitz A., Moretta A., Moretta L., Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 2005, 175:7989-7995.
36. Simhadri V.R., Andersen J.F., Calvo E., Choi S.C., Coligan J.E., Borrego F. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 2012, 119:2799-2809.
37. Nakahashi-Oda C., Tahara-Hanaoka S., Honda S., Shibuya K., Shibuya A. Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor. Biochem Biophys Res Commun 2012, 417:646-650.
38. Choi S.C., Simhadri V.R., Tian L., Gil-Krzewska A., Krzewski K., Borrego F., et al. Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J Immunol 2011, 187:3483-3487.
39. Cannon J.P., O'Driscoll M., Litman G.W. Specific lipid recognition is a general feature of CD300 and TREM molecules. Immunogenetics 2012, 64:39-47.
40. Marquez J.A., Galfre E., Dupeux F., Flot D., Moran O., Dimasi N. The crystal structure of the extracellular domain of the inhibitor receptor expressed on myeloid cells IREM-1. J Mol Biol 2007, 367:310-318.
41. Yamanishi Y., Kitaura J., Izawa K., Kaitani A., Komeno Y., Nakamura M., et al. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med 2010, 207:1501-1511.
42. Shi L., Luo K., Xia D., Chen T., Chen G., Jiang Y., et al. DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses. Blood 2006, 108:2678-2686.
43. Peluffo H., Ali-Ruiz D., Ejarque-Ortiz A., Heras-Alvarez V., Comas-Casellas E., Martinez-Barriocanal A., et al. Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury. Brain Pathol 2011.
44. Lee S.M., Kim E.J., Suk K., Lee W.H. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. J Immunol 2011, 186:6296-6303.
45. Kim E.J., Lee S.M., Suk K., Lee W.H. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines. Immunology 2012, 135:226-235.
46. Alvarez-Errico D., Sayos J., Lopez-Botet M. The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. J Immunol 2007, 178:808-816.
47. Martinez-Barriocanal A., Sayos J. Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J Immunol 2006, 177:2819-2830.
48. Lanier L.L. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009, 227:150-160.
49. Nakano-Yokomizo T., Tahara-Hanaoka S., Nakahashi-Oda C., Nabekura T., Tchao N.K., Kadosaki M., et al. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses. J Exp Med 2011, 208:1661-1671.
50. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000, 13:345-353.
51. Burnett A.K., Hills R.K., Milligan D., Kjeldsen L., Kell J., Russell N.H., et al. Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial. J Clin Oncol Offi J Am Soc Clin Oncol 2011, 29:369-377.
52. Brckalo T., Calzetti F., Pérez-Cabezas B., Borràs F.E., Cassatella M.A., López-Botet M. Functional analysis of the CD300e receptor in human monocytes and myeloid dendritic cells. Eur J Immunol 2010, 40:722-732.
53. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., Caligiuri M.A. NK cell and DC interactions. Trends Immunol 2004, 25:47-52.
54. Hardy M.Y., Kassianos A.J., Vulink A., Wilkinson R., Jongbloed S.L., Hart D.N., et al. NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells. Immunol Cell Biol 2009, 87:606-614.
55. Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011, 3:73ra19.
56. Cantoni C., Bottino C., Augugliaro R., Morelli L., Marcenaro E., Castriconi R., et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 1999, 29:3148-3159.
57. Munitz A., Bachelet I., Eliashar R., Moretta A., Moretta L., Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006, 107:1996-2003.
58. Simhadri V.R., Mariano J.L., Zhou Q., DeBell K.E., Borrego F. Differential expression of CD300a/c on human TH1 and TH17 cells. BMC Immunol 2011, 12:62.
59. + T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis. Am J Reprod Immunol 2012, 67:184-197.
60. Sabato V., Verweij M.M., Bridts C.H., Levi-Schaffer F., Gibbs B.F., De Clerck L.S., et al. CD300a is expressed on human basophils and seems to inhibit IgE/FcepsilonRI-dependent anaphylactic degranulation. Cytometry B Clin Cytom 2012, 82:132-138.
61. Silva R., Moir S., Kardava L., Debell K., Simhadri V.R., Ferrando-Martinez S., et al. CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection. Blood 2011, 117:5870-5880.
62. Jones L., Holmans P.A., Hamshere M.L., Harold D., Moskvina V., Ivanov D., et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PloS ONE 2010, 5:e13950.
63. Vernon S.D., Unger E.R., Dimulescu I.M., Rajeevan M., Reeves W.C. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 2002, 18:193-199.
64. Coustan-Smith E., Song G., Clark C., Key L., Liu P., Mehrpooya M., et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 2011, 117:6267-6276.
65. Burakoff R., Chao S., Perencevich M., Ying J., Friedman S., Makrauer F., et al. Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis 2011, 17:1719-1725.
66. Speckman R.A., Wright Daw J.A., Helms C., Duan S., Cao L., Taillon-Miller P., et al. Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum Genet 2003, 112:34-41.
67. + T lymphocyte subpopulations defined by CD300a/c molecule expression. J Leukoc Biol 2007, 82:1126-1135.
68. Munitz A., Bachelet I., Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 2006, 118:1082-1089.
69. Bachelet I., Munitz A., Berent-Maoz B., Mankuta D., Levi-Schaffer F. Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. J Immunol 2008, 180:6064-6069.
70. Bachelet I., Munitz A., Levi-Schaffer F. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 2006, 117:1314-1320.
71. Xi H., Katschke K.J., Helmy K.Y., Wark P.A., Kljavin N., Clark H., et al. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J Exp Med 2010, 207:7-16.
72. Korver W., Zhao X., Singh S., Pardoux C., Zhao J., Guzman M.L., et al. Monoclonal antibodies against IREM-1: potential for targeted therapy of AML. Leukemia Offi J Leukemia Soc Am Leukemia Res Fund, UK 2009, 23:1587-1597.